Small High-Risk Biotech Offers Potential Big Returns
Business 2 Community - Mon, Mar 4, 2013 12:45 PM ESTThe biotechnology sector provides some of the best investment opportunities for significant returns. This is especially true with the emerging smaller biotech companies that are in the early stages of clinical trials and commercialization. Yet the risk is high. Success in clinical trials from phases one to three could reap major price appreciation for shareholders.... More »Small High-Risk Biotech Offers Potential Big Returns
